Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
ELDER PHARMA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ELDER PHARMA Jun-14 |
TEVA PHARMA Dec-13 |
ELDER PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 380 | 3,461 | - | |
Low | Rs | 188 | 3,006 | - | |
Sales per share (Unadj.) | Rs | 489.2 | 1,986.1 | - | |
Earnings per share (Unadj.) | Rs | -3.2 | 124.1 | - | |
Cash flow per share (Unadj.) | Rs | 14.4 | 284.6 | - | |
Dividends per share (Unadj.) | Rs | 0 | 108.61 | - | |
Avg Dividend yield | % | 0 | 3.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 376.5 | 2,206.2 | - | |
Shares outstanding (eoy) | m | 20.54 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 1.6 | 35.7% | |
Avg P/E ratio | x | -89.3 | 26.1 | -342.7% | |
P/CF ratio (eoy) | x | 19.7 | 11.4 | 173.5% | |
Price / Book Value ratio | x | 0.8 | 1.5 | 51.5% | |
Dividend payout | % | 0 | 87.5 | -0.0% | |
Avg Mkt Cap | Rs m | 5,832 | 2,742,000 | 0.2% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 2,179 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,473.2 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,340.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 10,048 | 1,684,234 | 0.6% | |
Other income | Rs m | 257 | 0 | - | |
Total revenues | Rs m | 10,305 | 1,684,234 | 0.6% | |
Gross profit | Rs m | 2,921 | 461,228 | 0.6% | |
Depreciation | Rs m | 361 | 136,138 | 0.3% | |
Interest | Rs m | 2,756 | 33,081 | 8.3% | |
Profit before tax | Rs m | 60 | 292,009 | 0.0% | |
Minority Interest | Rs m | 0 | 1,327 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -191,688 | -0.0% | |
Tax | Rs m | 125 | -3,565 | -3.5% | |
Profit after tax | Rs m | -65 | 105,213 | -0.1% | |
Gross profit margin | % | 29.1 | 27.4 | 106.1% | |
Effective tax rate | % | 209.1 | -1.2 | -17,129.0% | |
Net profit margin | % | -0.6 | 6.2 | -10.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,240 | 1,137,525 | 0.8% | |
Current liabilities | Rs m | 9,998 | 992,018 | 1.0% | |
Net working cap to sales | % | -7.5 | 8.6 | -87.3% | |
Current ratio | x | 0.9 | 1.1 | 80.6% | |
Inventory Days | Days | 128 | 91 | 141.3% | |
Debtors Days | Days | 602 | 96 | 627.5% | |
Net fixed assets | Rs m | 13,642 | 550,108 | 2.5% | |
Share capital | Rs m | 206 | 4,146 | 5.0% | |
Net worth | Rs m | 7,733 | 1,870,864 | 0.4% | |
Long term debt | Rs m | 4,889 | 861,186 | 0.6% | |
Total assets | Rs m | 22,882 | 3,849,014 | 0.6% | |
Interest coverage | x | 1.0 | 9.8 | 10.4% | |
Debt to equity ratio | x | 0.6 | 0.5 | 137.3% | |
Sales to assets ratio | x | 0.4 | 0.4 | 100.4% | |
Return on assets | % | 11.8 | 3.6 | 327.3% | |
Return on equity | % | -0.8 | 5.6 | -15.0% | |
Return on capital | % | 22.3 | 4.9 | 452.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 11,754 | 268,380 | 4.4% | |
From Investments | Rs m | -561 | -95,098 | 0.6% | |
From Financial Activity | Rs m | -6,762 | -321,940 | 2.1% | |
Net Cashflow | Rs m | 5,466 | -148,658 | -3.7% |
Compare ELDER PHARMA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare ELDER PHARMA With: IND. SWIFT CONCORD DRUGS AMI ORGANICS GODAVARI DRU MANGALAM DRUGS
After opening the negative note, Indian share markets continued the downtrend as the session progressed and ended the day weak.